Factors influencing the pharmacokinetics, dosimetry, and diagnostic accuracy of radioimmunodetection and radioimmunotherapy of carcinoembryonic antigen-expressing tumors

Cancer Research

Volumn 56, Issue 8, 1996, Pages 1805-1816

  Behr, Thomas M ^a   Sharkey, Robert M ^a   Juweid, Malik I ^a   Dunn, Robert M ^a   Ying, Zhiliang ^b   Zhang, Cun H ^b   Siegel, Jeffry A ^c   Gold, David V ^a   Goldenberg, David M ^a  

^a CENTER FOR MOLECULAR MEDICINE AND IMMUNOLOGY   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c Department of Anesthesiology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER RADIOTHERAPY; COLORECTAL CANCER; DIAGNOSTIC ACCURACY; DOSE RESPONSE; FEMALE; HUMAN; ISOTOPE LABELING; LIVER METASTASIS; LUNG CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RADIATION DOSE; RADIOIMMUNOTHERAPY; SOLID TUMOR; THYROID MEDULLARY CARCINOMA;

ADOLESCENT; ADULT; AGED; ANTIBODIES, MONOCLONAL; BONE MARROW; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; HALF-LIFE; HUMANS; IMMUNOGLOBULIN G; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; NEOPLASMS; PATIENT SELECTION; RADIOIMMUNODETECTION; RADIOIMMUNOTHERAPY; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TISSUE DISTRIBUTION;

EID: 0029922060     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (69)

1. Goldenberg, D. M., DeLand, F. Kim, E., Bennett, S , Primus, F J., van Nagell, J. R., Estes, N., De Simone, P., and Rayburn, P Use of radiolabeled antibodies to carcinembryonic antigen for the detection and localization of diverse cancers by external photoscanning. N. Engl. J. Med., 298: 1384-1388, 1978
2. Kohler, G., and Milstein, C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature (Lond.), 256. 495-499, 1975.
3. 131I]anti-B1 (anti-CD20) antibody N Engl. J. Med , 329: 459-465, 1993.
4. Press, O. W., Eary, J F., Appelbaum, F. R., Martin, P J , Badger, C. C , Nelp, W. B., Glenn, S., Butchko, G., Fisher, D., Porter, B., Matthews, D C , Fisher, L D., and Bernstein, I. D Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support. N Engl. J. Med., 329: 1219-1224, 1993
5. 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphoma. Lancet, 346: 336-340, 1995
6. Behr, T. M., Sharkey, R. M., Juweid, M. E., Dunn, R. M., Vagg, R. C , Swayne, L C , Siegel, J. A., and Goldenberg, D. M. Radioimmunotherapy of CEA-expressing tumors: results of a phase I/II clinical trial Eur J Nucl. Med , 22: 818, 1995.
7. 131I-labeled anti-CEA antibodies: initial results. J. Nucl Med , in press, 1996.
8. 131I-labeled monoclonal antibodies to carcinoembryonic antigen Cancer Res , 55 (Suppl): 5946s-5951s, 1995.
9. Hird, V , Maraveyas, A., Snook, D., Dhokia, B., Soutter, W. P., Meares, C , Stewart, J S. W., Mason, P., Lambert, H E., and Epenetos, A. A. Adjuvant therapy of ovarian cancer with radioactive monoclonal antibody. Br. J. Cancer, 68: 403-406, 1993.
10. Pimm, M. V Circulating antigen: bad or good for immunoscintigraphy? Nucl. Med. Biol., 22: 137-145, 1995.
11. 99mTc: the role of metabolism and kinetics. Cancer Res., 55 (Suppl.): 5777s-5785s, 1995
12. 131I-COL-1 in patients with gastrointestinal (GI) malignancies: influence of serum CEA on pharmacokinetics. Proc Am. Soc Clin. Oncol., 12: 292, 1993.
13. Boerman, O. C , Sharkey, R M., Wong, G Y , Blumenthal, R D , Aninipot, R L., and Goldenberg, D M Influence of antibody protein dose on therapeutic efficacy of radioiodinated antibodies in nude mice bearing GW-39 human tumor. Cancer Immunol Immunother , 35: 127-134, 1992
14. 111In-labeled anticarcinoembryonic antigen monoclonal antibody in nude mice bearing colon cancer xenografts. Cancer Res., 49: 1587-1594, 1989.
15. Boerman, O. C., Sharkey, R M , Blumenthal, R. D., Aninipot, R. L., and Goldenberg, D M The presence of a concomitant bulky tumor can decrease the uptake and therapeutic efficacy of radiolabeled antibodies in small tumors. Int J. Cancer, 51, 470-475, 1992.
16. Sharkey, R M., Primus, F J , and Goldenberg, D. M Antibody protein dose and radioimmunodetection of GW-39 human colon tumor xenografts Int. J. Cancer, 39: 611-617, 1987.
17. Murray, J L , Mujoo, K., Wilmanns, C., Mansfield, P., Wilbur, D. S , and Rosenblum, M. G. Variables influencing tumor uptake of anti-melanoma monoclonal antibodies radioiodinated using para-iodobenzoyl (PIB) conjugate J Nucl Med , 32: 279-287, 1991
18. Patt, Y. Z., Lamki, L. M., Haynie, T. P., Unger, M. W., Rosenblum, M. G., Shirkhoda, A , and Murray, J L Improved tumor localization with increasing dose of indium-111-labeled anti-carcinoembryonic antigen monoclonal antibody ZCE-025 in metastatic colorectal cancer. J Clin Oncol., 6 1220-1230, 1988
19. Murray, J. L , Lamki, L. M., Shanken, L. J., Blake, M. E , Plager, C. E , Benjamin, R. S., Schweighardt, S., Unger, M. W., and Rosenblum, M G Immunospecific saturable clearance mechanisms for indium-111-labeled anti-melanoma monoclonal antibody 96.5 in humans. Cancer Res., 48: 4417-4422, 1988.
20. Murray, J. L., Rosenblum, M G., Lamki, L., Glenn, H J., Zdenko, K., Hersh, E. M., Plager, C. E., Bartholomew, R. M., Unger, M. W., and Carlo, D. J. Clinical parameters related to optimal tumor localization of indium-111-labeled mouse antimelanoma monoclonal antibody ZME-018. J. Nucl. Med., 28: 25-33, 1987
21. Halpern, S. E., Haindl, W., Beauregard, J., Hagan, P., Clutter, M , Amox, D , Merchant, B., Unger, M., Mongovi, C., Bartholomew, R., Jue, R., Carlo, D., and Dillman, R Scintigraphy with In-111-labeled monoclonal antitumor antibodies: kinetics, biodistribution, and tumor detection. Radiology, 168: 529-536, 1988.
22. 111indium labelled MoAb. Nucl. Med. Commun., 9: 553-564, 1988.
23. Abdel-Nabi, H. H., Levine, G., Lamki, L. M., Murray, J. L , Tauxe, W. N., Shah, A. N., Patt, Y. Z., Doerr, R. J , Klein, H. A , Gona, J., Rosenblum, M. J., Unger, M. J., Smith, L. M., Schweighardt, S. A , and Merchant, B. E. Colorectal carcinoma metastases: detection with In-111-labeled monoclonal antibody CCR 086 Radiology, 176: 117-122, 1990.
24. Sharkey, R. M., Goldenberg, D. M., Goldenberg, H., Lee, R E , Ballance, C., Pawlyk, D., Varga, D., and Hansen, H. J. Murine monoclonal antibodies against carcinoembryonic antigen: immunological, pharmacokinetic, and targeting properties in humans. Cancer Res., 50: 2823-2831, 1990.
25. Goldenberg, D. M , Wlodowski, T. J., Sharkey, R M., Silberstein, E. B., Serafini, A. N., Garty, I , Van Heertum, R. L , Higginbotham-Ford, E. A , Kotler, J. A., Balasubramian, N., Swayne, L. C , Hansen, H. J., and Pinsky, C. M. Colorectal cancer imaging with iodine-123-labeled CEA monoclonal antibody fragments. J. Nucl. Med., 34: 61-70, 1993.
26. Martin, K. W , and Halpern, S. E. Carcinoembryonic antigen production, secretion, and kinetics in BALB/c mice and a nude mouse-human tumor model. Cancer Res., 44: 5475-5481, 1984
27. Losman, M. J., DeJager, R. L., Monestier, M., Sharkey, R. M., and Goldenberg, D. M. Human immune response to anti-carcinoembryonic antigen murine monoclonal antibodies. Cancer Res., 50 (Suppl.): 1055s-1058s, 1990.
28. Ford, E H., Lee, R. E., Sharkey, R M., Alger, E. A., Horowitz, J. A , Hall, T. C , and Goldenberg, D. M. Effect of human anti-mouse antibody (HAMA) on monoclonal antibody (Mab) biokinetics and biodistribution during a phase I/II radioimmunotherapy clinical trial. J. Nucl. Med., 29: 761, 1988.
29. Courtenay-Luck, N S , Epenetos, A. A., Moore, R., Larche, M , Pectasides, D., Dhokia, B , and Ritter, M A. Development of primary and secondary immune responses to mouse monoclonal antibodies used in the diagnosis and therapy of malignant neoplasms. Cancer Res., 46: 6489-6493, 1986.
30. Nabi, H. A , and Maroli, A. HAMA response to repeated administration of In-111 satumomab pendetide (OncoScint™). Frequency and patterns of development. Proc Am. Assoc. Cancer Res., 35. 218, 1994.
31. Primus, F. J., Newell, K D , Blue, A , and Goldenberg, D M Immunological heterogeneity of carcinoembryonic antigen: antigenic determinants on carcinoembryonic antigen distinguished by monoclonal antibodies. Cancer Res., 43: 686-692, 1983
32. Primus, F. J., Kuhns, W. J , and Goldenberg, D M. Immunological heterogeneity of carcinoembryonic antigen: immunohistochemical detection of carcinoembryonic antigen determinants in colonic tumors with monoclonal antibodies. Cancer Res., 43: 693-701, 1983
33. Hansen, H. J., Goldenberg, D M., Newman, E. S., Grebenau, R., and Sharkey, R. M. Characterization of second-generation of second-generation monoclonal antibodies against carcinoembryonic antigen. Cancer (Phila.), 71: 3478-3485, 1993.
34. Sharkey, R. M , Goldenberg, D. M., Murthy, S., Pinsky, H , Vagg, R., Pawlyk, D., Siegel, J. A., Wong, G. Y., Gascon, P., Izon, D. O, Vezza, M., Burger, K., Swayne, L. C., Pinsky, C M , and Hansen, H J Clinical evaluation of tumor targeting with a high-affinity, anticarcinoembryonic-antigen-specific, murine monoclonal antibody. MN-14. Cancer (Phila.), 71: 2082-2096, 1993.
35. Sharkey, R. M., Juweid, M., Shevitz, J., Behr, T., Dunn, R , Swayne, L. C., Wong, G. Y., Blumenthal, R. D., Griffiths, G. L., Siegel, J A., Leung, S., Hansen, H. J., and Goldenberg, D. M. Evaluation of a complementarity-determining region-grafted (humanized) anti-carcinoembryonic antigen (CEA) monoclonal antibody in preclinical and clinical studies. Cancer Res., 55(Suppl.): 5935s-5945s, 1995.
36. Gold, D. V., Nocera, M A., Stephens, R., and Goldenberg, D. M. Murine monoclonal antibodies to colon-specific antigen-p Cancer Res., 50: 6405-6409, 1990.
37. Blumenthal, R. D., Kashi, R., Stephens, R., Sharkey, R. M., and Goldenberg, D. M. Improved radioimmunotherapy of colorectal cancer xenografts using antibody mixtures against carcinoembryonic antigen and colon-specific antigen-p. Cancer Immunol. Immunother , 32: 303-310, 1991
38. Sharkey, R M., Goldenberg, D. M., Vagg, R., Pawlyk, D , Wong, G. Y., Siegel, J A., Murthy, S , Levine, G. M., Izon, D., Gascon, P , Burger, K., Swayne, L. C., and Hansen, H. J. Phase I clinical evaluation of a new murine monoclonal antibody (Mu-9) against colon-specific antigen-p for targeting gastrointestinal carcinomas. Cancer (Phila), 73. 864-877, 1994
39. Weadock, K. S., Sharkey, R. M , Varga, D. C., and Goldenberg, D. M. Evaluation of a remote radioiodination system for radioimmunotherapy. J. Nucl. Med., 31: 508-511, 1990.
40. Primus, F J , Kelley, E. A , Hansen, H. J , and Goldenberg, D. M. "Sandwich"-type immunoassay for carcinoembryonic antigen in patients receiving murine monoclonal antibodies for diagnosis and management of cancer. Clin Chem , 34: 261-264, 1988.
41. Hansen, H. J , Sullivan, C L., Sharkey, R M., and Goldenberg, D. M. HAMA interference with murine monoclonal antibody-based immunoassays. J. Clin. Immunoassay, 16: 294-299, 1993
42. Wu, R. K , and Siegel, J. A. Absolute quantitation of radioactivity using the buildup factor. Med. Phys. (NY), 11: 189-192, 1984.
43. 131I-labeled anti-carcinoembryonic antigen monoclonal antibody. Cancer Res., 50 (Suppl.). 1039s-1042s, 1990.
44. Pawlyk, D. A., Siegel, J A , Sharkey, R. M., and Goldenberg, D. M. Automating large-scale processing of dosimetry data. J. Nucl Med., 34: 160P, 1993.
45. Dunn, R. M., Juweid, M. E., Behr, T. M., Siegel, J. A , Sharkey, R M., and Goldenberg, D. M. An automated internal dosimetry scheme for radiolabeled antibodies Med. Phys (Bruss.), 22: 1549-1550, 1995.
46. Snyder, W S., Ford, M. R., Warner, G G., and Watson, S B. "S" absorbed dose per unit cumulative activity for selected radionuclides and organs. Medical Internal Radiation Dose Pamphlet No. 11. New York: Society of Nuclear Medicine, 1976.
47. Sprent, P. Applied Nonparametric Statistical Methods, Ed. 2. London Chapman & Hall, 1993.
48. Becker, R. A., Chambers, J. M., and Wilks, A. R. The New S Language. A Program Environment for Data Analysis and Graphics. Pacific Grove, CA: Wadsworth & Brooks, 1988.
49. 2. J. Nucl Med., in press, 1996
50. Jain, R K , and Baxter, L. T. Mechanisms of heterogenous distribution of monoclonal antibodies and other macromolecules in tumors: significance of elevated interstitial pressure. Cancer Res., 48: 7022-7032, 1988.
51. Jain, R. K. Determination of tumor blood flow: a review Cancer Res., 48: 2641-2658, 1988.
52. van Osdol, W., Fujimori, K., and Weinstein, J. N An analysis of monoclonal antibody distribution in microscopic tumor nodules: consequences of a "binding site barrier." Cancer Res., 51: 4776-4784, 1991.
53. Juweid, M., Neumann, R., Paik, C., Perez-Bacete, M. J , Sato, J., van Osdol, W., and Weinstein, J. N. Micropharmacology of monoclonal antibodies in solid tumors: direct experimental evidence for a binding site barrier. Cancer Res., 52: 5144-5153, 1992.
54. 99mTc-labeled anti-CEA monoclonal antibodies for immunoscintigraphy in colorectal cancer J. Nucl Med., 36. 430-441, 1995.
55. Bosslet, K., Steinstrasser, A., Schwarz, A., Harthus, H P., Luben, G., Kuhlmann, L., and Sedlacek, H. H. Quantitative considerations supporting the irrelevance of circulating serum CEA for the immunoscintigraphic visualization of CEA expressing carcinomas. Eur J. Nucl. Med , 14: 523-528, 1988.
56. Thomas, P , Toth, C. A., Saini, K. S , Jessup, J. M., and Steele, G. The structure, metabolism and function of the carcinoembryonic antigen gene family. Biochim Biophys. Acta, 1032: 177-189, 1990.
57. Primus, F. J , Hansen, H. J., and Goldenberg, D. M Altered metabolism of carcinoembryonic antigen in hamsters bearing GW-39 tumours. Nature (Lond.), 249: 837-838, 1974
58. Watanabe, Y., Endo, K., Koizumi, M , Kawamura, Y., Saga, T , Sakahara, H., Kuroki, M., Matsuoka, Y., and Korushi, J. Effect of tumor mass and antigenic nature on the biodistribution of labeled monoclonal antibodies in mice Cancer Res , 49, 2884-2889, 1989.
59. Philben, V. J , Jakowatz, J G , Beatty, B. G., Vlahos, W. G., Paxton, R J., Williams, L. E., Shively, J. E., and Beatty, J. D. The effect of tumor CEA content and tumor size in tissue uptake of indium 111-labeled anti-CEA monoclonal antibody. Cancer (Phila.), 57: 571-576, 1986.
60. Hernando, J. J , von Kleist, S., and Grunert, F. A repertoire of monoclonal antibodies reveals extensive epitope heterogeneity in CEA purified from neoplasms originating from different organs. Int J. Cancer, 56: 655-661, 1994.
61. Chandrasekaran, E V., Davila, M. Nixon, D. W , Goldfarb, M., and Mendicino, J Isolation and structures of the oligosaccharide units of carcinoembryonic antigen. J. Biol Chem , 258: 7213-7222, 1983.
62. Bates, P. A , Luo, J , and Sternberg, M J E A predicted three-dimensional structure for the carcinoembryonic antigen (CEA). FEBS Lett., 301: 207-214, 1992
63. Rogers, G. T Heterogeneity of carcinoembryonic antigen: implications on its role as a tumour marker substance. Biochim Biophys. Acta, 458: 355-373, 1976.
64. Hagan, P. L., Halpern, S. E., Chen, A , Krishnan, L., Frinke, J., Bartholomew, R. M., David, G. S., and Carlo, D. In vivo kinetics of radiolabeled monoclonal anti-CEA antibodies in animal models. J. Nucl. Med., 26: 1418-1423, 1985.
65. Byrn, R A., Medrek, P , Thomas, P , Jeanloz, R W., and Zamchek, N Effect of heterogeneity of carcinoembryonic antigen on liver cell membrane binding and its kinetics of removal from circulation Cancer Res., 45: 3137-3142, 1985.
66. Schulz, G , Heckemann, R , and Bremer, K Beziehung zwischen Lebermelastasenvolumen und klinisch-chemischen Parametern. Tumordiagn Ther , 15: 197-202, 1994.
67. Fisher, D. Medical internal dosimetry for high-dose radionuclide therapies. In: D. M. Goldenberg (ed.), Cancer Therapy with Radiolabeled Antibodies, pp. 7-19 Boca Raton, FL: CRC Press, Inc., 1995.
68. Goldenberg, D. M , Sharkey, R. M , and Ford, E Anti-antibody enhancement of iodine-131 anti-CEA radioimmunodetection in experimental and clinical studies J. Nucl Med., 28: 1604-1610, 1987.
69. 111In-B72 3 (OncoScint CR-OV). Effect of administered activity. Nucl. Med Commun , 15: 981-990, 1994.